Suchergebnisse - "Härmark, Linda"

PubPharm (145)

21

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK

enthalten in: Drug safety | 2021

von de Vries, S. | Denig, P. | Andrić, A. | +4

22

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK

enthalten in: Drug safety | 2021

von de Vries, S. | Denig, P. | Andrić, A. | +4

23

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK

enthalten in: Drug safety | 2021

von de Vries, S. | Denig, P. | Andrić, A. | +4

24

Baseline assessment of Pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis

enthalten in: ResearchSquare.com | 2021

von Tiemersma, E. | Ibrahim, A. | Alemu, A. | +13

25

Online information discrepancies regarding safety of medicine use during pregnancy and lactation: an IMI ConcePTION study

enthalten in: Expert opinion on drug safety | 2021

von Nörby, U. | Noël-Cuppers, B. | Hristoskova, S. | +5

26

Insight in the safety profile of antidiabetic agents glucagon-like peptide-1 agonists and dipeptidyl peptidase-4 inhibitors in daily practice from the patient perspective

enthalten in: Pharmacoepidemiology and drug safety | 2020

von van Gorp, A. | Rolfes, L. | Härmark, L. | +3

27

Evaluation of a Web-Based, 'Purchase Event' Intensive Monitoring Method for Pharmacovigilance of Natural Health Products : Lessons and Insights from Development Work in New Zealand

enthalten in: Drug safety | 2020

von Barnes, J. | Sheridan, J. | Dong, C. | +3

28

Communicating Adverse Drug Reaction Insights Through Patient Organizations : Experiences from a Pilot Study in the Netherlands

enthalten in: Drug safety | 2020

von Härmark, L. | Weits, G. | Meijer, R. | +3

ErratumIn: Drug Saf. 2020 Jul 2;:. - PMID 32617875

29

Correction to : Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

enthalten in: Drug safety | 2020

von Härmark, L. | Weits, G. | Meijer, R. | +3

ErratumFor: Drug Saf. 2020 Aug;43(8):745-749. - PMID 32418193

30

Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

enthalten in: Drug safety | 2020

von Härmark, L. | Weits, G. | Meijer, R. | +3